NLGIA
CLB icon

Nippon Life Global Investors Americas’s Core Laboratories CLB Stock Holding History

Nippon Life Global Investors Americas’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-11,130
Closed -$1.21M – 124
2015
Q4 		$1.21M Sell
11,130
-6,730
-38% -$770K 0.11% 121
2015
Q3 		$1.78M Buy
+17,860
New +$1.94M 0.18% 106

Other funds holding CLB

ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
WP
Wedgewood Partners St Louis, Missouri $484M AUM 14.59% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

Nippon Life Global Investors Americas's CLB Position: Q1 2016 in Review

Nippon Life Global Investors Americas sold out of Core Laboratories (CLB) in Q1 2016, closing a stake of 11,130 shares — an estimated $1.21M sold.

Nippon Life Global Investors Americas first reported a position in CLB in Q3 2015 and held it in 2 quarters. The position peaked at $1.78M in Q3 2015. 366 funds tracked by Wall St. Rank hold CLB as of Q1 2016.

  • Nippon Life Global Investors Americas reported no remaining Core Laboratories position as of Q1 2016 after selling out during the quarter.
  • Nippon Life Global Investors Americas sold 11,130 Core Laboratories shares in Q1 2016, an estimated $1.21M.
  • Nippon Life Global Investors Americas first reported a position in Core Laboratories in Q3 2015 and held it in 2 quarters.
  • Nippon Life Global Investors Americas's Core Laboratories position peaked at $1.78M in Q3 2015.
  • 366 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2016.

Based on Nippon Life Global Investors Americas's 13F filing for Q1 2016, filed 12 May 2016.